Picture of Wuhan YZY Biopharma logo

2496 — Wuhan YZY Biopharma News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Wuhan Yzy Biopharma Says Y225 Receives IND Approval From NMPA

Dec 24 (Reuters) - Wuhan YZY Biopharma 2496.HK:

Y225 ‘‘EMICIZUMAB INJECTION" RECEIVES IND APPROVAL FROM NMPA

Further company coverage: 2496.HK

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Wuhan YZY Biopharma

See all news